Surgical Offloading Procedures for Diabetic Foot Ulcers

Sponsor
Assaf Harofeh MC (Other)
Overall Status
Unknown status
CT.gov ID
NCT03414216
Collaborator
(none)
100
2
22

Study Details

Study Description

Brief Summary

100 consenting subjects with Texas grade 1a diabetic foot ulcers will be randomized to surgical offloading or non-operative offloading.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Group 1 early offloading surgery
  • Procedure: Group 2 - off-loading in fiberglass cast
N/A

Detailed Description

Background: Diabetic foot ulcers are frequently related to elevated pressure under a bony prominence. Conservative treatment includes offloading with orthopaedic shoes and custom made orthotics or plaster casts. While casting in plaster is usually effective in achieving primary closure of foot ulcers, recurrence rates are high. Minimally invasive surgical offloading that includes correction of foot deformities has good short and long term results. The surgery alleviates the pressure under the bony prominence, thus enabling prompt ulcer healing, negating the patient's dependence on expensive shoes and orthotics, with a lower chance of recurrence. The purpose of this protocol is to compare offloading surgery (percutaneous flexor tenotomy, mini-invasive floating metatarsal osteotomy or Keller arthroplasty) to non-surgical treatment for patients with diabetic foot ulcers in a crossover designed RCT.

Methods: 100 patients with diabetic neuropathy related foot ulcers (tip of toe ulcers, ulcers under metatarsal heads and ulcers under the hallux interphalangeal joint) will be randomized (2:3) to a surgical offloading procedure or best available non-surgical treatment. Group 1 (surgery) will have surgery within 1 week. Group 2 (controls) will be prescribed an offloading cast applied for up to 12 weeks (based on clinical considerations). Following successful offloading treatment (ulcer closure with complete epithelization) patients will be prescribed orthopaedic shoes and custom made orthotics. If offloading by cast for at least 6 weeks fails, or the ulcer recurs, patients will be offered surgical offloading. Follow-up will take place till 2 years following randomization. Outcome criteria will be time to healing of the primary ulcer (complete epithelization), time to healing of surgical wound, recurrence of ulcer, time to recurrence and complications.

Discussion: The high recurrence rate of foot ulcers and their dire consequences justify attempts to find better solutions that the non-surgical options available at present. To promote surgery, randomized controlled trial (RCT) level evidence of efficacy is necessary.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Surgical Offloading Procedures for Diabetic Foot Ulcers Compared to Best Non-surgical Treatment
Anticipated Study Start Date :
Mar 1, 2018
Anticipated Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group1 - early off-loading surgery

Within 1 week of randomization, offloading surgery: Tip of toe ulcers will be treated by percutaneous tenotomy. Ulcers under metatarsal heads will be offloaded with minimally invasive floating metatarsal osteotomy. Ulcers plantar to the interphalangeal joint of the hallux will be treated by a modified Keller resection arthroplasty.

Procedure: Group 1 early offloading surgery
As above.

Active Comparator: Group 2 - off-loading in fiberglass cast

Tip of toe ulcers and ulcers plantar to the interphalangeal joint of the big toe will be casted in a fiberglass cast with a heel, ending under the metatarsal heads, leaving the toes in the air. Ulcers under metatarsal heads will be casted in a full foot fiberglass cast with a heel with a window below the ulcer designed to relieve pressure under the metatarsal heads.

Procedure: Group 2 - off-loading in fiberglass cast
As above.

Outcome Measures

Primary Outcome Measures

  1. Failure to cure [12 weeks]

    Lack of full epithelization

  2. Any recurrence of any ulcer at same location [2 years]

    If either of the outcomes is positive, the case will be counted as a failure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Single Texas A1 or A2 ulcer.

  • ulcer attributable to an anatomic deformity.

Exclusion Criteria:
  • Unable to understand language of informed consent.

  • Ischemia.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assaf Harofeh MC

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assaf Harofeh MC, Senior Orthopaedic Surgeon, Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT03414216
Other Study ID Numbers:
  • 0094-17-ASF
First Posted:
Jan 29, 2018
Last Update Posted:
Jan 29, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2018